TrialCancer immunology, immunotherapy : CII2025

Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).

Yuantai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.